TVRD · Categories · Form 4
TVRD - SEC Form 4 insider transactions
Tvardi Therapeutics Inc. (TVRD) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for TVRD
- SEC Form 4 filed by Chief Financial Officer Conn Avi Daniel4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- SEC Form 4 filed by Principal Accounting Officer O'Brien Stephen Paul4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Kauh John Saewook M.D.4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Alibhai Imran Nizamudin4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Alibhai Imran Nizamudin4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Conn Avi Daniel4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Kauh John Saewook M.D.4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- SEC Form 4 filed by Principal Accounting Officer O'Brien Stephen Paul4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- Large owner Tweardy Samuel David disposed of 631,316 shares (SEC Form 4)4 - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- Amendment: Director Hall Wallace L Jr was granted 246,756 shares (SEC Form 4)4/A - Tvardi Therapeutics, Inc. (0001346830) (Issuer)
- Amendment: Director Wirk Shaheen was granted 439,194 shares (SEC Form 4)4/A - Tvardi Therapeutics, Inc. (0001346830) (Issuer)